Table 2.
Median follow-up | 22.4 mo |
Range | 1.0–39.1 mo |
Primary immunosuppression | |
Cyclosporinea | 314 (45.4%) |
FK506 | 377 (54.6%) |
M/F ratio | 405:286 |
Age (yr)b | 47.7 ± 12.3 |
UNOS classification at time of transplant | |
1,2 | 85 (12.4%) |
3 | 260 (37.6%) |
4 | 174 (25.2%) |
5 | 172 (24.9%) |
FK 506 was available if necessary.
Data expressed as mean ± S.D.